Acumen Pharmaceuticals

$4.99 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Acumen Pharmaceuticals

Acumen Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing a novel disease-modifying approach to target causes of Alzheimer's disease. Acumen Pharmaceuticals serves customers worldwide.

Stock Analysis

last close $5.04
1-mo return -26.7%
3-mo return -62.6%
avg daily vol. 137.93T
52-week high 26.98
52-week low 5.04
market cap. $218M
forward pe -
annual div. -
roe -
ltg forecast -
dividend yield -
annual rev. $0M
inst own. 77%
baraka

Subscribe now for daily local and international financial news

Subscribe